Elisabeth D Martinez

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi Falling off the academic bandwagon. Women are more likely to quit at the postdoc to principal investigator transition
    Elisabeth D Martinez
    Postdoctoral Fellows Subcommittee, Second Task Force, Status of NIH Intramural Women Scientists, National Institutes of Health, Bethesda, MD, USA
    EMBO Rep 8:977-81. 2007
  2. ncbi Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions
    Susan Holbeck
    National Cancer Institute, National Institutes of Health, Rockville, Maryland 20852, USA
    Mol Endocrinol 24:1287-96. 2010

Research Grants

  1. Characterization of small molecule inhibitors of HDACs and DNMTs
    Elisabeth Martinez; Fiscal Year: 2007
  2. Characterization of the biological activities of novel epigenetic modulators
    Elisabeth D Martinez; Fiscal Year: 2010

Collaborators

  • Susan Holbeck
  • Jianjun Chang
  • David J Mangelsdorf
  • Angie L Bookout
  • Anne M Best

Detail Information

Publications2

  1. ncbi Falling off the academic bandwagon. Women are more likely to quit at the postdoc to principal investigator transition
    Elisabeth D Martinez
    Postdoctoral Fellows Subcommittee, Second Task Force, Status of NIH Intramural Women Scientists, National Institutes of Health, Bethesda, MD, USA
    EMBO Rep 8:977-81. 2007
  2. ncbi Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions
    Susan Holbeck
    National Cancer Institute, National Institutes of Health, Rockville, Maryland 20852, USA
    Mol Endocrinol 24:1287-96. 2010
    ....

Research Grants3

  1. Characterization of small molecule inhibitors of HDACs and DNMTs
    Elisabeth Martinez; Fiscal Year: 2007
    ..Using this system, we have already identified eight candidate drugs and propose to characterize them measuring their ability to block the growth of human cancer cells. ..
  2. Characterization of the biological activities of novel epigenetic modulators
    Elisabeth D Martinez; Fiscal Year: 2010
    ..Here, we propose to define how this drug works and to further develop it for therapeutic applications. ..